Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Editorial Contact
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Editorial Contact
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow SNMMI on Twitter
  • Visit SNMMI on Facebook
In BriefThis Month in JNM

This Month in JNM

Journal of Nuclear Medicine September 2011, 52 (9) 11A-12A;
  • Article
  • Info & Metrics
  • PDF
Loading

MRI and tumor biochemistry: Gallagher and colleagues provide an overview of hyperpolarized 13C MR spectroscopic imaging and compare sensitivity, spatial and temporal resolution, and risks with those of PET imaging.Page 1333

Figure1

P-selectin cardiovascular imaging: Boersma and colleagues look at the potential challenges for imaging this adhesion molecule and activation marker in atherosclerotic disease and preview a related article in this issue of JNM.Page 1337

18F-fluoropaclitaxel PET/CT: Kurdziel and colleagues describe radiation dosimetry and imaging studies in healthy adults and women with breast cancer and the potential for use of intratumoral 18F-fluoropaclitaxel distribution as a surrogate for paclitaxel in solid tumors.Page 1339

Figure2

Hand-held preoperative SLN camera: Kerrou and colleagues compare the effectiveness of a hand-held preoperative compact γ-camera for sentinel lymph node detection in breast cancer with that of conventional lymphoscintigraphy.Page 1346

Network assessment of lymphoma RIT: Hohloch and colleagues present the work of the Radioimmunotherapy Network, a Web-based international registry collecting long-term observational data about radioimmunotherapy-treated patients with malignant lymphoma outside randomized clinical studies.Page 1354

Quality of life after 177Lu-octreotate: Khan and colleagues investigate quality of life and symptoms after therapy with this peptide-receptor radionuclide therapy in patients with inoperable or metastasized gastroenteropancreatic or bronchial neuroendocrine tumorsPage 1361

Coronary function and metabolic syndrome: Di Carli and colleagues explore the hypothesis that metabolic syndrome is associated with impaired coronary vasodilator function, a marker of atherosclerotic disease activity.Page 1369

123I-MIBG uptake in pulmonary emphysema: Suga and colleagues evaluate impaired lung uptake of 123I-MIBG on SPECT in patients with pulmonary emphysema and compare the results with those from perfusion SPECT and morphologic CT.Page 1378

PET and cervical myelopathy: Floeth and colleagues investigate the role of 18F-FDG PET in patients with degenerative stenosis of the cervical spinal cord and look at correlations with postsurgical outcomes.Page 1385

MRI-based AC for PET/MR: Hofmann and colleagues assess 2 algorithms for whole-body MRI-based PET attenuation correction and describe potential benefits for routine clinical hybrid PET/MRI.Page 1392

Figure3

SPECT and carotid endarterectomy: Sato and colleagues research the ability of preoperative central benzodiazepine receptor binding potential and cerebral blood flow imaging with SPECT to identify patients at risk for new cerebral ischemic events after carotid endarterectomy.Page 1400

Thrombus in aneurysm on PET/CT: Muzaffar and colleagues evaluate the incidence of aneurysm and the frequency of thrombus within an aneurysm on unenhanced 18F-FDG PET/CT studies.Page 1408

Figure4

Somatostatin receptor antagonist imaging: Wild and colleagues describe somatostatin receptor antagonist imaging studies in patients with metastatic thyroid carcinoma or neuroendocrine tumors and discuss the advantages such imaging would provide in peptide receptor–mediated imaging and therapy.Page 1412

131I-MIBG extravasation: Bonta and colleagues report on a new catheter placement protocol for therapeutic administration of 131I-MIBG and detail the extravasation incident that prompted institution of this protocol.Page 1418

Figure5

Fukushima accident response perspectives: Dauer and colleagues offer an educational review of the short-term chronology, radiologic consequences, emergency responses, and long-term challenges associated with the March 2011 nuclear power facility events in Japan.Page 1423

Figure6

P-selectin imaging with 99mTc-fucoidan: Rouzet and colleagues propose a new approach to molecular imaging of overexpression of platelet and endothelial P-selectin.Page 1433

18F-octreotate PET: Leyton and colleagues compare in vitro affinity and tissue pharmacokinetics of 5 structurally related 19F/18F-fluoroethyltriazole-Tyr3-octreotate analogs and discuss the potential for more rapid clinical protocols for gastroenteropancreatic neuroendocrine tumor imaging with PET.Page 1441

α7nAChR PET tracer: Ettrup and colleagues offer details on 11C-NS14492, a selective α7 nicotinic acetylcholine receptor agonist PET radioligand that may prove useful in evaluation and selection of appropriate drug candidates in schizophrenia and Alzheimer disease.Page 1449

Quantum dot EGFR imaging: Jung and colleagues explore the potential of a novel quantum dot–based technique targeting the epidermal growth factor receptor, with promise for quantitatively monitoring receptor status and treatment response in breast cancerPage 1457

Figure7

RIT agent for AML: Leyton and colleagues characterize 111In-nuclear translocation sequence-7G3, an Auger electron–emitting radioimmunotherapeutic agent with potentially beneficial applications in acute myelogenous leukemia.Page 1465

Figure8

Dosimetry of 99mTc-HYNIC-TOC: Grimes and colleagues report on the biodistribution and radiation dosimetry of this somatostatin receptor–targeting agent in patients with suspected neuroendocrine tumors undergoing whole-body dynamic planar and SPECT/CT imaging.Page 1474

Figure9

MRI assessment of marrow cellularity: Pichardo and colleagues extend the IDEAL technique for estimating fat fractions to the derivation of data for estimation of patient-specific bone marrow mass using published predictive equations.Page 1482

Figure10

First-in-human study of BMS747158: Maddahi and colleagues evaluate radiation dosimetry, biodistribution, safety, tolerability, and early elimination in urine of a single injected dose of this 18F-labeled myocardial perfusion imaging tracer that targets mitochondrial complex 1.Page 1490

ON THE COVER

Figure11

99mTc-fucoidan has been found to be a relevant imaging agent for in vivo detection of biologic activities associated with P-selectin overexpression, such as arterial thrombus and ischemic memory, and overcomes some limitations of previous P-selectin–targeted agents. In the above SPECT/CT slices of a rat with aortic valve endocarditis, 99mTc-fucoidan uptake is seen in the aortic valve area. See page 1436.

  • © 2011 by Society of Nuclear Medicine
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 52 (9)
Journal of Nuclear Medicine
Vol. 52, Issue 9
September 1, 2011
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
This Month in JNM
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
This Month in JNM
Journal of Nuclear Medicine Sep 2011, 52 (9) 11A-12A;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
This Month in JNM
Journal of Nuclear Medicine Sep 2011, 52 (9) 11A-12A;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • ON THE COVER
  • Info & Metrics
  • PDF

Related Articles

  • Preoperative Central Benzodiazepine Receptor Binding Potential and Cerebral Blood Flow Images on SPECT Predict Development of New Cerebral Ischemic Events and Cerebral Hyperperfusion After Carotid Endarterectomy
  • Radioimmunotherapy Confers Long-Term Survival to Lymphoma Patients with Acceptable Toxicity: Registry Analysis by the International Radioimmunotherapy Network
  • Prognostic Value of 18F-FDG PET in Monosegmental Stenosis and Myelopathy of the Cervical Spinal Cord
  • Hyperpolarized 13C MRI and PET: In Vivo Tumor Biochemistry
  • Targeting Somatostatin Receptors: Preclinical Evaluation of Novel 18F-Fluoroethyltriazole-Tyr3-Octreotate Analogs for PET
  • Phase I, First-in-Human Study of BMS747158, a Novel 18F-Labeled Tracer for Myocardial Perfusion PET: Dosimetry, Biodistribution, Safety, and Imaging Characteristics After a Single Injection at Rest
  • Human Dosimetry and Preliminary Tumor Distribution of 18F-Fluoropaclitaxel in Healthy Volunteers and Newly Diagnosed Breast Cancer Patients Using PET/CT
  • 11C-NS14492 as a Novel PET Radioligand for Imaging Cerebral α7 Nicotinic Acetylcholine Receptors: In Vivo Evaluation and Drug Occupancy Measurements
  • Impaired Lung 123I-MIBG Uptake on SPECT in Pulmonary Emphysema
  • P-Selectin Imaging in Cardiovascular Disease: What You See Is What You Get?
  • Patient-Specific Radiation Dosimetry of 99mTc-HYNIC-Tyr3-Octreotide in Neuroendocrine Tumors
  • The Usefulness of a Preoperative Compact Imager, a Hand-Held γ-Camera for Breast Cancer Sentinel Node Biopsy: Final Results of a Prospective Double-Blind, Clinical Study
  • Incidental Diagnosis of Thrombus Within an Aneurysm on 18F-FDG PET/CT: Frequency in 926 Patients
  • Quality of Life in 265 Patients with Gastroenteropancreatic or Bronchial Neuroendocrine Tumors Treated with [177Lu-DOTA0,Tyr3]Octreotate
  • First Clinical Evidence That Imaging with Somatostatin Receptor Antagonists Is Feasible
  • Extravasation of a Therapeutic Dose of 131I-Metaiodobenzylguanidine: Prevention, Dosimetry, and Mitigation
  • 99mTc-Hydrazinonicotinamide Epidermal Growth Factor–Polyethylene Glycol–Quantum Dot Imaging Allows Quantification of Breast Cancer Epidermal Growth Factor Receptor Expression and Monitors Receptor Downregulation in Response to Cetuximab Therapy
  • The Japanese Tsunami and Resulting Nuclear Emergency at the Fukushima Daiichi Power Facility: Technical, Radiologic, and Response Perspectives
  • Auger Electron Radioimmunotherapeutic Agent Specific for the CD123+/CD131− Phenotype of the Leukemia Stem Cell Population
  • Radiolabeled Fucoidan as a P-Selectin Targeting Agent for In Vivo Imaging of Platelet-Rich Thrombus and Endothelial Activation
  • Coronary Circulatory Function in Patients with the Metabolic Syndrome
  • MRI Measurement of Bone Marrow Cellularity for Radiation Dosimetry
  • MRI-Based Attenuation Correction for Whole-Body PET/MRI: Quantitative Evaluation of Segmentation- and Atlas-Based Methods
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • This Month in JNM
  • This Month in JNM
  • This Month in JNM
Show more This Month in JNM

Similar Articles

SNMMI

© 2021 Journal of Nuclear Medicine

Powered by HighWire